Company page

Cabaletta Bio, Inc.

Cabaletta Bio, Inc. is a public biotechnology company based in the United States, trading under the ticker CABA. The company focuses on developing innovative therapies for autoimmune diseases. With a market capitalization of approximately $490.8 million, Cabaletta Bio is positioned within the growing biotech sector.